SLN

#3225
Silence Therapeutics Plc American Depository Share
7.28 USD
+18.95%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
7.28
7.28
Intervallo Annuale
2.63
7.91
Variazione giornaliera
+18.95%
Variazione Mensile
-2.93%
Variazione di 6 mesi
+12.35%
Variazione Annuale
+155.44%
Chiusura Precedente
6.12
Apertura
7.28
Bid
Ask
Minimo
7.28
High
7.28
Volume
38
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche
Trimestrale Annuale
  • Market Capitalization 343.86 M
  • Employee 88
  • Founded 1994
  • CEO Craig A Tooman
  • Website www.silence-therapeutics.com
  • Headquarter United Kingdom
  • FIGI BBG00WVTHPN2
  • Industry Technology
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-9.65
Rapporto prezzo/fatturato
1 541.15

Silence Therapeutics Plc - American Depository Share

Silence Therapeutics is a London-based pharmaceutical company formed in 1994. The company has pioneered the development of short-interfering ribonucleic acid therapeutics for the treatment of rare diseases. Silence Therapeutics has offices in London, New Jersey, and Berlin, with its corporate headquarters located in Hammersmith, London.

Notizie